| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $1.06B | — | +12.4% |
| Cost of Revenue | $649.1M | — | +13.9% |
| Gross Profit | $410.2M | — | +10.3% |
| R&D Expense | $62.7M | — | +1.0% |
| SG&A Expense | $76.3M | — | +2.1% |
| Operating Income | $117.3M | — | +40.2% |
| Pre-tax Income | $96.8M | — | +65.4% |
| Income Tax | $23.6M | — | +66.1% |
| Net Income | $73.3M | — | +67.1% |
| EPS (Basic) | $1.25 | — | +68.9% |
| EPS (Diluted) | $1.24 | — | +69.9% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $265.5M | -22.2% | +41.6% |
| Accounts Receivable | $626.6M | +4.0% | +6.2% |
| Inventory | $1.25B | +0.2% | +14.3% |
| Current Assets | $2.45B | -0.5% | +23.2% |
| Total Assets | $5.59B | +0.4% | +10.5% |
| Current Liabilities | $1.21B | -0.6% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | $119.3M | — | +105.1% |
| Capital Expenditures | $29.4M | — | -5.0% |
| Investing Cash Flow | -$153.8M | — | -358.4% |
| Financing Cash Flow | -$41.4M | — | +65.4% |
| Free Cash Flow | $89.9M | — | +230.3% |
| +19.9% |
| Long-term Debt | $1.19B | -0.1% | -0.3% |
| Total Liabilities | $2.92B | -0.6% | +12.8% |
| Stockholders' Equity | $2.67B | +1.6% | +8.3% |